Analysis of activating somatic mutations in codons 12, 13, 59, 61, 117 and 146 of the NRAS gene with a sensitivity of 1% in cancer cells
The test involves analyzing DNA from tumor cellsórecords due to the listed mutations in the KRAS gene, often found in cases of colorectal cancer, and helps predict the course of the disease and response to drugs.

Synevo
Lowest price from 30 days before discounting PLN 1,420.00
- Test description
- Documents
Analysis of activating somatic mutations at codons 12, 13, 59, 61, 117 and 146 of the NRAS gene with a sensitivity of 1% in cancer cells
Clinical relevance
Analysis of activating somatic mutations at codons 12, 13, 59, 61, 117 and 146 of the NRAS gene with a sensitivity of 1% in cancer cells
Patient preparation
Material: EDTA blood
Blood